These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18643828)

  • 1. Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax.
    Isukapalli SS; Lioy PJ; Georgopoulos PG
    Risk Anal; 2008 Jun; 28(3):723-40. PubMed ID: 18643828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bayesian aerosol release detector: an algorithm for detecting and characterizing outbreaks caused by an atmospheric release of Bacillus anthracis.
    Hogan WR; Cooper GF; Wallstrom GL; Wagner MM; Depinay JM
    Stat Med; 2007 Dec; 26(29):5225-52. PubMed ID: 17948918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responding to the threat of bioterrorism: a microbial ecology perspective--the case of anthrax.
    Atlas RM
    Int Microbiol; 2002 Dec; 5(4):161-7. PubMed ID: 12497181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Tool for Decision Support during Early Days of an Anthrax Event.
    Rainisch G; Meltzer MI; Shadomy S; Bower WA; Hupert N
    Emerg Infect Dis; 2017 Jan; 23(1):46-55. PubMed ID: 27983505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anthrax--the Swedish perspective].
    Tegnell A; Hellers M; Wollin R; Eriksson U; Forsman M; Engstrand L; Elgh F
    Lakartidningen; 2001 Dec; 98(50):5742-5. PubMed ID: 11789095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001.
    Holtz TH; Ackelsberg J; Kool JL; Rosselli R; Marfin A; Matte T; Beatrice ST; Heller MB; Hewett D; Moskin LC; Bunning ML; Layton M
    Emerg Infect Dis; 2003 Jun; 9(6):689-96. PubMed ID: 12781008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center.
    Sanderson WT; Stoddard RR; Echt AS; Piacitelli CA; Kim D; Horan J; Davies MM; McCleery RE; Muller P; Schnorr TM; Ward EM; Hales TR
    J Appl Microbiol; 2004; 96(5):1048-56. PubMed ID: 15078521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pakistan's experience of a bioterrorism-related anthrax scare.
    Ahmad K; Dil AS; Kazi BM; Us-Saba N; Ansari J; Nomani K
    East Mediterr Health J; 2004; 10(1-2):19-26. PubMed ID: 16201705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax in New Jersey: a health education experience in bioterrorism response and preparedness.
    Miro S; Kaufman SG
    Health Promot Pract; 2005 Oct; 6(4):430-6. PubMed ID: 16210685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-Response Modeling for Inhalational Anthrax in Rabbits Following Single or Multiple Exposures.
    Gutting BW; Rukhin A; Marchette D; Mackie RS; Thran B
    Risk Anal; 2016 Nov; 36(11):2031-2038. PubMed ID: 26889937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the location and spatial extent of a covert anthrax release.
    Legrand J; Egan JR; Hall IM; Cauchemez S; Leach S; Ferguson NM
    PLoS Comput Biol; 2009 Jan; 5(1):e1000356. PubMed ID: 19360099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the incubation period of inhalational anthrax.
    Wilkening DA
    Med Decis Making; 2008; 28(4):593-605. PubMed ID: 18556642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmark dose analysis for Bacillus anthracis inhalation exposures in the nonhuman primate.
    Taft SC; Hines SA
    Risk Anal; 2012 Oct; 32(10):1750-68. PubMed ID: 22469218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation modeling of anthrax spore dispersion in a bioterrorism incident.
    Reshetin VP; Regens JL
    Risk Anal; 2003 Dec; 23(6):1135-45. PubMed ID: 14641889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.